SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016986
Filing Date
2017-08-09
Accepted
2017-08-09 16:27:15
Documents
44
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q wve-10q_20170630.htm 10-Q 1103812
2 EX-31.1 wve-ex311_14.htm EX-31.1 14931
3 EX-31.2 wve-ex312_8.htm EX-31.2 15036
4 EX-32 wve-ex32_10.htm EX-32 9238
  Complete submission text file 0001564590-17-016986.txt   2987700

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT wve-20170630.xml EX-101.INS 392302
6 XBRL TAXONOMY EXTENSION SCHEMA wve-20170630.xsd EX-101.SCH 27102
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20170630_cal.xml EX-101.CAL 33115
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20170630_def.xml EX-101.DEF 77423
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20170630_lab.xml EX-101.LAB 220154
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20170630_pre.xml EX-101.PRE 162953
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
WAVE Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 171018295
SIC: 2834 Pharmaceutical Preparations